F
Fenghua Peng
Researcher at Central South University
Publications - 35
Citations - 248
Fenghua Peng is an academic researcher from Central South University. The author has contributed to research in topics: Transplantation & Kidney transplantation. The author has an hindex of 8, co-authored 29 publications receiving 203 citations.
Papers
More filters
Journal ArticleDOI
Population pharmacokinetics of voriconazole and CYP2C19 polymorphisms for optimizing dosing regimens in renal transplant recipients.
Xiao-bin Lin,Xiao-bin Lin,Zi‐wei Li,Zi‐wei Li,Miao Yan,Bikui Zhang,Wu Liang,Feng Wang,Ping Xu,Da-Xiong Xiang,Xubiao Xie,Shaojie Yu,Gongbin Lan,Fenghua Peng +13 more
TL;DR: The pharmacokinetics of voriconazole in renal transplant recipients is characterized and factors significantly affecting pharmacokinetic parameters are identified to explore the optimal dosing regimens for patients who developed invasive fungal infections.
Journal ArticleDOI
Roles of mitochondrial transcription factor A and microRNA-590-3p in the development of bladder cancer
TL;DR: It is suggested that TFAM, a direct target of miRNA-590-3p, may play a significant role in the tumorigenesis of bladder cancer and thus may be a promising target for cancer therapeutics.
Journal ArticleDOI
MicroRNA‑126 inhibits proliferation and metastasis by targeting pik3r2 in prostate cancer.
TL;DR: Results revealed that aberrant expression of miR-126 promoted the progression of PCa and may serve as a novel therapeutic biomarker for PCa.
Journal ArticleDOI
Cancer risks in recipients of renal transplants: a meta-analysis of cohort studies.
TL;DR: It is suggested that patients who receive renal transplantation have an increased risk of cancer at most sites, apart from uterine and prostate cancers patients.
Journal ArticleDOI
Anti-OX40L monoclonal antibody prolongs secondary heart allograft survival based on CD40/CD40L and LFA-1/ICAM-1 blockade.
Helong Dai,Fenghua Peng,Lin Minjie,Junjie Xia,Shaojie Yu,Gongbin Lan,Yu Wang,Xubiao Xie,Chunhua Fang,Matthias Corbascio,Zhongquan Qi,Longkai Peng +11 more
TL;DR: The mechanism of protecting allografts using anti-OX40L mAb involved impairing the generation of Tm and up-regulating IL-10 producing Tregs, inhibiting the function of T cells.